February 20, 2008 - Siemens Healthcare announces an exclusive partnership with Prowess Inc. to develop advanced radiation oncology treatment planning software for integration into Siemens' linear accelerators.

This agreement authorizes Siemens Healthcare to share the basic intellectual property of Prowess' patented Direct Aperture Optimization (DAO) planning software, allowing Siemens to incorporate Prowess’ software into the treatment planning tools for its linear accelerators, which, according to Siemens, will help users to reduce the number of segments, monitor units and treatment times.

The Prowess DAO-based Plan-to-Patient tool for Adaptive Radiation Therapy (ART) has been clinically evaluated and is planned to be available in the spring of 2008. The tool works with Siemens' CTVision System, a SOMATOM CT Sliding Gantry on rails combined with an ARTISTE or ONCOR Linear Accelerator. DAO reportedly enables users to make on-line plan corrections based on actual pre-treatment CT scans taken in the treatment room, while the patient is on the linear accelerator’s treatment table.

Siemens is also working on the development of a single arc radiation treatment called Cone Beam Therapy (CBT). The combination of CBT with DAO-based planning software will help improve tumor control for many disease sites, while sparing as much healthy tissue as possible, according to Siemens.

For more information: www.usa.siemens.com/healthcare


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now